AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.12.18	AstraZeneca Closes Sale Of Rights To Nexium In Europe, Vimovo Worldwide(ex-US) (RTTNews)
26.11.18	AstraZeneca: FDA Grants Orphan Drug Designation For Fasenra For EGPA (RTTNews)
16.11.18	AstraZeneca: MYSTIC Trial Fails To Meet Significance In Overall Survival (RTTNews)
13.11.18	AstraZeneca To Divest U.S. Synagis Rights To Sobi (RTTNews)
12.11.18	AstraZeneca Announces Positive Results From DECLARE-TIMI 58 CV Outcomes Trial (RTTNews)
08.11.18	AstraZeneca Q3 Profit Declines, Product Sales Rise; Backs FY18 View (RTTNews)
06.11.18	AstraZeneca Divests Rights To Alvesco, Omnaris, Zetonna To Covis Pharma (RTTNews)
30.10.18	AstraZeneca To Divest Rights To Nexium In Europe, Vimovo Worldwide, Ex-US (RTTNews)
23.10.18	Innate Pharma Expands Oncology Development Collaboration With AstraZeneca (RTTNews)
21.10.18	AstraZeneca, Merck Announce Results From Phase 3 SOLO-1 Trial On LYNPARZA 300 Mg (RTTNews)
19.10.18	AstraZeneca: CHMP Adopts Positive Opinion For Bevespi Aerosphere - Quick Facts (RTTNews)
16.10.18	AstraZeneca, Merck Announce Fourth Orphan Drug Designation For LYNPARZA (RTTNews)
16.10.18	AstraZeneca, Merck Get FDA's ODD For Lynparza For Pancreatic Cancer (RTTNews)
28.09.18	Biotech Stocks Facing FDA Decision In October (RTTNews)
25.09.18	AstraZeneca, MedImmune: Imfinzi Significantly Improved OS In PACIFIC Trial (RTTNews)
25.09.18	AstraZeneca : EU Approves Imfinzi For Locally-advanced, Unresectable NSCLC (RTTNews)
24.09.18	AstraZeneca: Farxiga Met Primary Goal In Phase III Cardiovascular Outcomes Trial (RTTNews)
18.09.18	AstraZeneca: FASENRA Shows Consistent Safety, Efficacy In Phase III BORA Trial (RTTNews)
17.09.18	AstraZeneca: KRONOS Phase III Trial Met Eight Of Nine Primary Endpoints (RTTNews)
14.09.18	FDA Okays AstraZeneca's Lumoxiti For Rare Form Of Blood Cancer (RTTNews)
07.09.18	AstraZeneca, Amgen Announce Breakthrough Therapy Designation For Tezepelumab (RTTNews)
06.09.18	AstraZeneca Appoints Former Nissan CFO Joseph Peter As Non-Executive Director (RTTNews)
31.08.18	AZN : TULIP 1 Phase III Trial For Anifrolumab Fails To Meet Primary Endpoint (RTTNews)
30.08.18	AstraZeneca: EC Approves Bydureon BCise Device For T2 Diabetes - Quick Facts (RTTNews)
23.08.18	AstraZeneca Reports Top-line Results From AERISTO Phase IIIb Trial - Quick Facts (RTTNews)
21.08.18	AstraZeneca Reports Approval Of Tagrisso In Japan - Quick Facts (RTTNews)
15.08.18	AstraZeneca Prices Global Bond Offering Of $3 Bln (RTTNews)
26.07.18	AstraZeneca Q2 Profit Declines; Reiterates FY18 Outlook - Quick Facts (RTTNews)
24.07.18	AstraZeneca To Sell Atacand Rights In Europe To Cheplapharm - Quick Facts (RTTNews)
02.07.18	AstraZeneca: Cancer Drugs Imfinzi, Lynparza Approved In Japan (RTTNews)
28.06.18	AstraZeneca Completes Agreement With Luye Pharma On Seroquel (RTTNews)
27.06.18	Merck, AstraZeneca: Ovarian Cancer Drug LYNPARZA Meets Primary Goal In Trial (RTTNews)
13.06.18	CAH Closer To FDA Approval, Another Alzheimer's Disease Drug Fails, VTVT Tanks (RTTNews)
12.06.18	AstraZeneca, Eli Lilly To Discontinue Lanabecestat Trials In Alzheimer's (RTTNews)
07.06.18	Seroquel Stepping Stone: How Luye Will Use Seroquel to Expand in Emerging Markets (PR Newswire)
07.06.18	Seroquel Stepping Stone: How Luye Will Use Seroquel to Expand in Emerging Markets (PR Newswire)
01.06.18	In The Spotlight: Sesen Bio (RTTNews)
30.05.18	AstraZeneca Says TERRANOVA Trial Fails To Meet Primary Endpoint In COPD (RTTNews)
25.05.18	AstraZeneca: Imfinzi Meets Second Primary Endpoint Of Overall Survival (RTTNews)
24.05.18	AstraZeneca To Present 91 Accepted Abstracts At ASCO - Quick Facts (RTTNews)
22.05.18	It's Raining FDA Approvals, NBRV, SESN Hit Trial Goals But Fail To Make A Mark (RTTNews)
21.05.18	AstraZeneca: FDA Approves Lokelma To Treat Adults With Hyperkalaemia (RTTNews)
21.05.18	AstraZeneca Reports Regulatory Submission In Japan For Forxiga - Quick Facts (RTTNews)
19.05.18	AstraZeneca Shareholder Approves All Resolutions (RTTNews)
18.05.18	AstraZeneca Stock Dips On Weak Q1 Profit; Backs FY18 View (RTTNews)
12.05.18	An Ear To The Pharma: 8 Stocks To Watch (VYGR, BOLD, RXII, CYAD…) (RTTNews)
11.05.18	AstraZeneca Says GALATHEA Phase III Trial Fails To Meet Primary Endpoint (RTTNews)
08.05.18	MRK :EU Oks LYNPARZA Tablets To Treat Platinum-Sensitive Relapsed Ovarian Cancer (RTTNews)
08.05.18	AstraZeneca And Luye Pharma Reach Agreement For Seroquel (RTTNews)
27.04.18	AstraZeneca Says Tagrisso Receives Positive EU CHMP Opinion (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

18.12.24		Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer
04.12.24		Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich
03.12.24		Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende
03.12.24		Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus
03.12.24		Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück
03.12.24		NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer
12.11.24		AstraZeneca-Aktie im Minus: AstraZeneca meldet starkes 3. Quartal und passt Prognose nach oben an
07.11.24		AstraZeneca-Aktie rutscht ab: Festnahme des China-Chefs von AstraZeneca

18.12.24

Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer

04.12.24

Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich

03.12.24

Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende

03.12.24

Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus

03.12.24

Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück

03.12.24

NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer